Navigation Links
Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD

nhance the free radical scavenging capacity of the heart, thereby protecting against I-R injury.

The finding, which is corroborated by empirical evidence of the Schisandra berry as cardio-tonic in Traditional Chinese Medicine for hundreds of years, supports the use of Schisandrin B in the prevention and treatment of IHD.

Since the publication of this finding, Dr. Ko has identified an isomer of Schisandrin B, (-) Schisandrin B, a novel discovery, which possesses a more potent pharmacological profile than that of Schisandrin B. Patented use of this newly discovered compound, (-) Schisandrin B, for the prevention and treatment of Ischemic Heart Disease has been applied for with the US Patent and Trademark Office.

For a copy of this research report, please contact the publisher, Molecular and Cellular Biochemistry.

About the Company

MitoPharm Corporation is a biotechnology company in the research & development, marketing and sale of drugs, dietary supplements, and functional beverages. The initial products are based on a newly discovered compound (the "Compound") that is the result of over 15 years of research and development by one of its founding shareholders, the Hong Kong University of Science and Technology ("HKUST"). MitoPharm believes that its products have the potential to play a significant role in addressing the aging concerns of the baby boomers, the heart-health and heart-diseases markets, and the segment of the population that is physically active. www.mitopharm.com

At HKUST, scientific studies have identified biochemical actions of MitoPharm's key Compound, demonstrating that it enhances the mitochondrial glutathione antioxidant status, a crucial factor in maintaining mitochondrial function and cell survival, and also induces the expression of heat shock proteins, another group of important molecules for cell protection. Management's research indicates that these biochemical actions differentiate the Compound f
'"/>




Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:10/6/2008)...he door to the understanding of and possible ...ancer, BILLERICA, Mass., Oct. 6 /- S...the first ever analytical instrument for the,kinet... and cytoplasmic,glycolysis in cells in a 96 well ...ing cellular bioenergetics have been relatively un...
(Date:10/6/2008)...tudies with Durezol Dosed Prior to Surgery, TAMPA..., Inc., a,privately held ophthalmic-focused biopha...TM) (difluprednate ophthalmic emulsion) 0.05% is n...oved by the U.S. Food and,Drug Administration in J...ndicated for the treatment of inflammation and pai...
(Date:10/6/2008)...ll Scheduled for 9:00 AM ET Today -, SEATTLE, Oct... (Nasdaq:,DNDN) announced today that it has comple...andomized, double-blind, placebo-controlled IMPACT...ent, also known as D9902B),clinical trial designed...ational active cellular immunotherapy PROVENGE(R) ...
(Date:10/6/2008)...at drinking polyphenol-rich 100% Concord grape,jui...ergy intake or body,weight, CONCORD, Mass., Oct. ...phenol-rich Concord grape juice did not cause sign...es in appetite and was shown to reduce waist,circu...th Annual Meeting of,the American College of Nutri...
Breaking Medicine Technology:Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference 2642 1New Benefactors Show Support for CDA4CDT 3A 2638 1New Benefactors Show Support for CDA4CDT 3A 2638 2New Benefactors Show Support for CDA4CDT 3A 2638 3New Benefactors Show Support for CDA4CDT 3A 2638 4New Benefactors Show Support for CDA4CDT 3A 2638 5New Benefactors Show Support for CDA4CDT 3A 2638 6New Benefactors Show Support for CDA4CDT 3A 2638 7Newly discovered virus linked to deadly skin cancer 9721 1Newly discovered virus linked to deadly skin cancer 9721 2Newly discovered virus linked to deadly skin cancer 9721 3Newly discovered virus linked to deadly skin cancer 9721 4Gene That Creates Cerebral Cortex Discovered 9718 1
...ly to subsequently,respond, have substantially mor...ange in treatment strategy, COLORADO SPRINGS, Colo...ta presented at the 2007 International Congress on...sychotic drug,response be assessed earlier than is...zophrenia treatment paradigm for when to,evaluate ...
...ector National,Alliance on Mental Illness (NAMI), ...ire/ -- Today,the Archives of General Psychiatry p...ial treatments for bipolar disorder,"Psychosocial...w up,study to one released last Thursday in the Ne...tidepressants in the treatment of,bipolar disorder...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Latest NIMH Study on Bipolar Disorder 2Latest NIMH Study on Bipolar Disorder 3
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...e-to-speech" project in Singapore is using a custo...ally improve the lives of the intellectually disab...ing with homemade pictures, the handheld innovatio...express their needs in such everyday tasks as orde...
...reated with Interferon (IFN)to treat chronic hepa... during treatment phase itself//. Retinopathy can ...tment, says the researchers in a study published ...gy & Visual Science (IOVS)in the January 2007 iss...
...t government-run hospitals in Rajasthan will now h...instead of a brand name//, according to Health Min...this regard to all government medical colleges, ho...ntres, community health centres and dispensaries,"...
...y dwellings were thought to be far cleaner and hea...itish researchers say this is not true- inner citi.... Market analysts CACI and TNS analyzed smoking a... understand the unhealthiest places in England, Wa...
Other Medicine News:
...is the latest addition to the HemoCue glucose prod...ystem combines the precision and accuracy of a lab...and ease of use. The new pocket size analyser also... and time for up to 600 measurements. The stored d...
VIDAS tests are presented in individual, ready to use form. Each test is composed of a strip and a SPR. The strip contains all the reagent required for the reaction (buffer, conjugate and substrate.
ELISA for the detection of C. difficile toxin A in stool specimens
Clostridium difficile Toxin A Rapydtest® is a fast, simple and highly sensitive test for the rapid and reliable detection of C. difficile Toxins A in faeces.
Medicine Products: